PTSM: Pharmaceutical Technology Sourcing and Management-01-06-2010

Buoyed by an uptick in financing from partnering deals, the US biotechnology industry reached a record high in private and public financing in 2009, but caution remains for 2010.

Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.

Despite a challenging current economic environment, the five-year outlook for pharmaceutical outsourcing and ingredients supply is fairly healthy.